Cargando…

Fibrinolytic therapy for COVID-19: a review of case series

Detalles Bibliográficos
Autores principales: Ji, Hong-Long, Dai, Yuling, Zhao, Runzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661828/
https://www.ncbi.nlm.nih.gov/pubmed/34893684
http://dx.doi.org/10.1038/s41401-021-00827-w
_version_ 1784613391518662656
author Ji, Hong-Long
Dai, Yuling
Zhao, Runzhen
author_facet Ji, Hong-Long
Dai, Yuling
Zhao, Runzhen
author_sort Ji, Hong-Long
collection PubMed
description
format Online
Article
Text
id pubmed-8661828
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-86618282021-12-10 Fibrinolytic therapy for COVID-19: a review of case series Ji, Hong-Long Dai, Yuling Zhao, Runzhen Acta Pharmacol Sin Correspondence Springer Nature Singapore 2021-12-10 2022-08 /pmc/articles/PMC8661828/ /pubmed/34893684 http://dx.doi.org/10.1038/s41401-021-00827-w Text en © The Author(s), under exclusive licence to CPS and SIMM 2021
spellingShingle Correspondence
Ji, Hong-Long
Dai, Yuling
Zhao, Runzhen
Fibrinolytic therapy for COVID-19: a review of case series
title Fibrinolytic therapy for COVID-19: a review of case series
title_full Fibrinolytic therapy for COVID-19: a review of case series
title_fullStr Fibrinolytic therapy for COVID-19: a review of case series
title_full_unstemmed Fibrinolytic therapy for COVID-19: a review of case series
title_short Fibrinolytic therapy for COVID-19: a review of case series
title_sort fibrinolytic therapy for covid-19: a review of case series
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661828/
https://www.ncbi.nlm.nih.gov/pubmed/34893684
http://dx.doi.org/10.1038/s41401-021-00827-w
work_keys_str_mv AT jihonglong fibrinolytictherapyforcovid19areviewofcaseseries
AT daiyuling fibrinolytictherapyforcovid19areviewofcaseseries
AT zhaorunzhen fibrinolytictherapyforcovid19areviewofcaseseries